Navigation Links
Norgen Biotek Corp. Launches a Novel kit to Collect, Concentrate, Preserve and Isolate DNA, RNA, microRNA and proteins from Urine Specimens
Date:9/14/2010

THOROLD, ON, Sept. 14 /PRNewswire/ - Norgen Biotek Corp, a privately held Canadian biotechnology company focusing principally on advancing a powerful proprietary technology for application in sample preparation for nucleic acid (DNA, RNA and microRNA) and protein purification, today announced the expansion of its basket of urine-based sample preparation products by launching 3 new urine concentration, preservation and isolation kits. With the launch of these novel kits Norgen now has the largest basket of kits to preserve, concentrate and purify macromolecules such as DNA, RNA, microRNA, proteins, exfoliated cells and microorganisms from less than 1 ml up to 30 ml of urine for the use in diagnostics and biomarker discovery research.

These kits provide a fast, robust, reliable and simple method for urine collection, concentration, preservation as well as isolation of high quality urine DNA, RNA, microRNA and proteins for a variety of applications such as PCR, RT-PCR, qPCR, qRT-PCR, microarrays, etc. The kits contain a Urine Concentration and Preservation Device which allows for rapid and simple urine concentration without the use of centrifugation, as well as preservation of DNA/RNA/proteins in urine samples at ambient temperature. This simplifies the transportation of specimens from the clinic or field (resource limited areas) to the lab, as there is no requirement for refrigeration or freezing. The urine DNA, RNA and proteins in preserved samples are stable for a year at room temperature. The provided Urine Preservative also prevents the growth of bacteria and fungi and inactivates viruses, thus collected urine specimens can be safely shipped concentrated (50X) at ambient temperature.

A unique feature of this Urine Concentration and Preservation Device is that it also allows for the isolation of DNA, RNA, miRNA, proteins without the use of centrifugation and therefore can be used in the field in a resource limited setting. The ability to easily concentrate and ship urine at room temperature is especially attractive for self administered urine specimen collection, concentration and preservation. The availability of this device will make it possible to conduct various population studies, including studies on sexually transmitted infections.

We have also made our Urine Preservative available to researchers in both liquid format and dried format in various sized tubes to allow the collection of urine in any amount suitable for any assay. This will enable customers to have a one stop shop for all urine preservation and transport.

"Our mission is to bring to market innovative Best-in-Class sample preparation kits that can be used in research as well as in diagnostic applications. Indeed, we have been diligently working on adopting these cutting edge sample preparation tools to develop First-In-Class non-invasive point-of-care diagnostic kits" Said Dr. Yousef Haj-Ahmad, President & CEO of Norgen Biotek.

About Norgen Biotek Corp. -------------------------

Norgen Biotek is a rapidly growing privately-held Canadian biotechnology company specialized in the research, development, manufacture and marketing of a variety of commercial products derived from its proprietary technology. Currently, this technology is used in protein, RNA and DNA purification and clean-up kits. Norgen is also bundling its sample preparation technology into the diagnostic kits. Additional information is available on the company's website: www.norgenbiotek.com.

DNA, RNA, microRNA, Proteins, Exfoliated Cells and Microorganism


'/>"/>
SOURCE Norgen Biotek Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Norgen Biotek Corp. Announces OEM Manufacturing & Supply Agreement with Exiqon A/S
2. Norgen Biotek Launches 10 New Kits for the Isolation of High-Quality Circulating Nucleic Acids from Blood, Plasma and Serum
3. Norgen Biotek Transitions into Diagnostics with the Launch of over 30 New Kits for Nucleic Acid-Based Diagnostics
4. BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
5. InstaCare Corp. Continues Turnaround & Reports 291% Revenues Increase in 2Q 2008
6. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal 2008 on September 9, 2008
7. BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease
8. Aegis Analytical Corp. Showcases Discoverant at Inaugural Venture Capital in the Rockies Fall
9. BioElectronics Corp. Announces $400,000 in New Orders From the Middle East
10. BioSpecifics Technologies Corp. Announces Appointment of Dr. Matthew Geller to Board of Directors
11. Cantel Medical Corp. To Hold Conference call to Discuss Fourth Quarter and Fiscal 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... , Feb. 16, 2017  Champions Oncology, Inc. ... the development and sale of advanced technology solutions and ... drugs, today announced the addition of new cohorts of ... These new models will expand Champions, product line in ... and neck cancer, AML, and non-small cell lung cancer ...
(Date:2/16/2017)... NEW YORK , Feb. 16, 2017 ... $7M Series B financing, adding an additional $3M from ... by Mesa Verde Venture Partners and other strategic partners ... directed towards further accelerating commercial adoption of their flagship ... test and expanding the Paradigm cancer registry. ...
(Date:2/15/2017)... , 15. Februar 2017  Trianni, Inc. ... Biotech, Inc. (Janssen) eine Lizenzvereinbarung über die Verwendung ... Klasse führenden Plattform für die Entdeckung monoklonaler Antikörper. ... ihr neuartiges chimäres Gensegmentdesign aus, das Janssen ... humanen Antikörpern bietet und das für die schelle ...
(Date:2/15/2017)... 15, 2017 Windtree Therapeutics, Inc. (Nasdaq: ... aerosolized KL4 surfactant therapies for respiratory diseases, will host ... at 8:00 AM EST on Thursday, February 16, 2017 ... program, the recently announced closing of a $10.5 million ... To participate in the live call and take ...
Breaking Biology Technology:
(Date:2/6/2017)... DENVER , Feb. 6, 2017 ... national security are driving border authorities to continue ... Acuity reports there are 2143 Automated Border Control ... Kiosks currently deployed at more than 163 ports ... between 2013 to 2016 achieving a combined CAGR ...
(Date:2/2/2017)... 2017   TapImmune, Inc. (NASDAQ: ... in the development of innovative peptide and gene-based ... and metastatic disease, announced today it has successfully ... a second clinical lot of TPIV 200, the ... The manufactured vaccine product will be used to ...
(Date:2/1/2017)... Massachusetts , February 1, 2017 IDTechEx ... events on emerging technology, announces the availability of a new report, ... Continue Reading ... ... in industrial and collaborative robots. Source: IDTechEx Report "Sensors for Robotics: ...
Breaking Biology News(10 mins):